RecruitingNCT06374277
About this title
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Read the official source — NCT06374277Official study titlePharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
In MemphisAnxiety, DepressionPlacebo comparisonAges 18+
- Countries
- United States
- Sponsor
- University of Tennessee
RecruitingNCT07029581
About this title
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Read the official source — NCT07029581Official study titleA Double-Blind, Placebo-Controlled, Phase 2, Efficacy and Safety Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)
Multiple locations, including IrvineSchizophreniaMedication studyAges 55–84
- Countries
- United States, France, Bulgaria, + 3 others
- Sponsor
- ACADIA Pharmaceuticals Inc.
RecruitingNCT06559306
About this title
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Read the official source — NCT06559306Official study titleA Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-(Milligram) mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms
Multiple locations, including TucsonDepressionMedication studyAges 18–74
- Countries
- United States, Argentina, Brazil, + 13 others
- Sponsor
- Janssen Research & Development, LLC
RecruitingNCT07095465
About this title
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
Read the official source — NCT07095465Official study title52-Week, Phase 3, Open-Label Extension Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)
Multiple locations, including IrvineSchizophreniaMedication studyAges 55–84
- Countries
- United States, France, Bulgaria, + 3 others
- Sponsor
- ACADIA Pharmaceuticals Inc.